Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion].

Moche M, Hui DS, Huse K, Chan KS, Choy DK, Scholz GH, Gosse H, Winkler J, Schauer J, Sack U, Hoheisel G.

Pneumologie. 2005 Aug;59(8):523-8. German.

PMID:
16110415
2.

Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.

Hoheisel G, Sack U, Hui DS, Huse K, Chan KS, Chan KK, Hartwig K, Schuster E, Scholz GH, Schauer J.

Tuberculosis (Edinb). 2001;81(3):203-9.

PMID:
11466032
3.

Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors.

Rossignol P, Cambillau M, Bissery A, Mouradian D, Benetos A, Michel JB, Plouin PF, Chatellier G, Jacob MP.

Clin Exp Pharmacol Physiol. 2008 Apr;35(4):464-9. doi: 10.1111/j.1440-1681.2008.04897.x.

PMID:
18307742
4.

Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.

Park KJ, Hwang SC, Sheen SS, Oh YJ, Han JH, Lee KB.

Respiration. 2005 Mar-Apr;72(2):166-75.

PMID:
15824527
5.

[Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].

Hoheisel G, Sack U, Hui DS, Lai F, Chan KS, Choi CH, Schauer J, Tannapfel A.

Pneumologie. 2004 May;58(5):305-8. German.

PMID:
15162254
6.

Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in exudative pleural effusions.

Vatansever S, Gelisgen R, Uzun H, Yurt S, Kosar F.

Clin Invest Med. 2009 Aug 1;32(4):E293-300.

PMID:
19640333
7.

Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.

Wilson EM, Gunasinghe HR, Coker ML, Sprunger P, Lee-Jackson D, Bozkurt B, Deswal A, Mann DL, Spinale FG.

J Card Fail. 2002 Dec;8(6):390-8.

PMID:
12528092
8.

[Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].

Yang YJ, Zhang X, Zhu WL, Huang Y.

Zhonghua Yi Xue Za Zhi. 2006 Jun 27;86(24):1693-6. Chinese.

PMID:
16854324
9.

Matrix metalloproteinases and their inhibitors in malignant and autoreactive pericardial effusion.

Lamparter S, Schoppet M, Christ M, Pankuweit S, Maisch B.

Am J Cardiol. 2005 May 1;95(9):1065-9.

PMID:
15842972
10.
11.

Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease.

Rosemar A, Ivarsson ML, Börjesson L, Holmdahl L.

Scand J Gastroenterol. 2007 Feb;42(2):215-20.

PMID:
17327941
12.

Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis.

Tsai HC, Ye SY, Kunin CM, Lee SS, Wann SR, Tai MH, Shi MH, Liu YC, Chen YS.

Cytokine. 2011 May;54(2):109-16. doi: 10.1016/j.cyto.2011.02.007. Epub 2011 Feb 26.

PMID:
21354815
13.

Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.

Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, Spinale FG, Zile MR.

Circulation. 2006 May 2;113(17):2089-96. Epub 2006 Apr 24.

14.

Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.

Yang K, Palm J, König J, Seeland U, Rosenkranz S, Feiden W, Rübe C, Rübe CE.

Int J Radiat Biol. 2007 Oct;83(10):665-76.

PMID:
17729161
15.

MMP and TIMP expression pattern in pleural effusions of different origins.

Eickelberg O, Sommerfeld CO, Wyser C, Tamm M, Reichenberger F, Bardin PG, Solèr M, Roth M, Perruchoud AP.

Am J Respir Crit Care Med. 1997 Dec;156(6):1987-92.

PMID:
9412584
16.

Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.

Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J, Treska V.

Anticancer Res. 2009 Jul;29(7):2513-7.

17.

Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions.

Iglesias D, Alegre J, Alemán C, Ruíz E, Soriano T, Armadans LI, Segura RM, Anglés A, Monasterio J, de Sevilla TF.

Eur Respir J. 2005 Jan;25(1):104-9.

19.

Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.

Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS, Crumbley AJ 3rd, Spinale FG, Gold MR.

Am J Cardiol. 2006 Feb 15;97(4):532-7. Epub 2006 Jan 4.

PMID:
16461051
20.

Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.

Fondard O, Detaint D, Iung B, Choqueux C, Adle-Biassette H, Jarraya M, Hvass U, Couetil JP, Henin D, Michel JB, Vahanian A, Jacob MP.

Eur Heart J. 2005 Jul;26(13):1333-41. Epub 2005 Apr 12.

PMID:
15827062

Supplemental Content

Support Center